Alexion Pharmaceuticals (ALXN) News 149.42 $ALXN Integra

New Post Public Reply Private Reply Replies (0) Message Board

Mar 29, 2014 at 10:42 AM

Alexion Pharmaceuticals (ALXN) News 149.42 $ALXN

Integra LifeSciences Introduces Wound Matrix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:34PM CDT
New Jersey-based Integra LifeSciences Holding Corporation (IART) has expanded its skin and wound product line with the launch of Integra Wound Matrix (Thin).

CVS Caremark Receives FEP contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:10PM CDT
CVS Caremark received the Federal Employee Program contract to render integrated pharmacy benefit services for a period of three years.

Gilead's HCV Candidate Under Review in the EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 10:40AM CDT
Gilead's combination HCV therapy is under review in the EU.

BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 10:30AM CDT
BioDelivery Sciences signs deal with Quintiles for supporting the anticipated launch of BioDelivery Sciences' Bunavail

Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:46AM CDT
Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as the company saw its shares shoot up nearly 13% on the day.

Insmed Incorporated saw its shares rise more than 7% in the session. - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 8:04AM CDT
Insmed Incorporated was a big mover last session, as the company saw its shares rise more than 7% on the day.

MEI Pharma, Inc. (MEIP) in Focus: Stock up 12.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:44AM CDT
MEI Pharma, Inc. was a big mover last session, as the company saw its shares rise over 12% on the day.

Exelixis' Cometriq Approved in the EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 5:00PM CDT
Exelixis received approval for Cometriq in the EU for the treatment of progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC).

Insmed Down on Disappointing Arikayce Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 4:48PM CDT
Insmed shares skid over 13% after the company announced that Arikayce failed to meet the primary objective.

Nektar Rises on FDA Notification (revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 1:50PM CDT
If approved, naloxegol would be the first once-daily oral treatment for patients with chronic OIC.

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 10:00AM CDT
Amidst the excitement about the Bristol-Myers deal, Five Prime reported its fourth quarter 2013 results.

China Cord Blood Corporation (CO) Soars: Stock Up 5.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 8:39AM CDT
China Cord Blood Corporation was a big mover last session, as its shares rose nearly 6% on the day.

Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:44AM CDT
Keryx Biopharmaceuticals Inc. was a big mover last session, as the company saw its shares shoot up over 17% on the day.

Retrophin (RTRX) Catches Eye: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 8:54AM CDT
Retrophin was a big mover last session, with shares rising nearly 8% on the day.

1 Big Reason to Doubt the Biotech Bubble Chorus
Keith Speights, The Motley Fool - Motley Fool - Wed Mar 26, 8:30AM CDT
Raise your hand if you've heard the words "biotech" and "bubble" used in the same sentence recently. Observers from virtually every corner have joined the chorus singing the blues about the biotech sector. Some might even be humming a funeral dirge....

The Zacks Analyst Blog Highlights: IShares NASDAQ Biotechnology ETF, Gilead, Alexion Pharmaceuticals, Amgen and Myriad Genetics
PR Newswire - Wed Mar 26, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the the IShares NASDAQ Biotechnology ETF (AMEX:IBB-Free Report), Gilead (Nasdaq:GILD-Free Report), Alexion Pharmaceuticals (Nasdaq:ALXN-Free Report), Amgen Inc (Nasdaq:AMGN-Free Report) and Myriad Genetics Inc (Nasdaq:MYGN-Free Report) .

What Falling Estimates & Price Mean for Kythera (KYTH) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
It may be a good decision to sell Kythera as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a Zacks Rank #4 confirms weakness.

Time to Focus on Alexion (ALXN) for Strong Earnings Growth Potential - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:51AM CDT
Alexion is well-positioned for future earnings growth and could be a strong growth stock contender

Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:44AM CDT
Galectin Therapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day.

Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Actavis plc Ordinary Shares (NYSE: ACT), Thermo Fisher Scientific Inc. (NYSE: TMO), and Medtronic, Inc. (NYSE: MDT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ademi LLP Questions RRC Buyout Deal's Fairness

Unease Surrounds RRC's Potential Acquisition by EQT Let’s talk about a messy situation brewing with Range Resources Corporation (NYSE: RRC). The lawyers at Ademi LLP are poking around in the shadows of a proposed buyout by EQT Corporation, questioning whether the deal is legit—or if someone’s getting the short end of the stick. It’s all happening in a climate...

Worldline Crowned as 2026 SPARK Matrix Leader

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...

Small Gestures Making a Big Difference Ah, Thanksgiving—a time of turkey, stuffing, and cranberries, with grocery receipts long enough to make your eyes water. And wouldn't you know, Dudley DeBosier Injury Lawyers is stepping in with a little relief, dishing out $2,000 in gift cards. This Louisiana-based law firm is giving away ten $200 gift cards to residents just in...

Switchgear Monitoring Market Surges to $3.80 Billion

Switchgear Monitoring: A Crucial Component in Modern Power Grids When the chips are down, it's the grid that keeps the lights on. Now, looks like switchgear monitoring systems are riding high on this global necessity. Fueled by infrastructure upgrades, the market's slated to leap from $2.36 billion in 2026 to a whopping $3.80 billion by 2031, clocking a solid 10.1% CAGR....

Modal's $750M Raise Shakes Up AI Valuations

Modal's Bold Leap with a $750 Million Raise Alright, if you're even dabbling in stocks or keeping tabs on tech, let me fill you in on today's headliner—Modal just bagged a hefty $750 million in a Series D round, rocketing its valuation to a whopping $15.75 billion. Now, that's no pocket change, and it's enough to make even the most seasoned trader stop and take a hard...

China Leads Electrification; US Faces Stagnation Risk

China Races Ahead in Electrification If you ever doubted China's resolve to lead the green charge, the latest Electrification Competitiveness Index should make you think again. They're pacing ahead, while the rest of the world seems content with playing catch-up. Created by the savvy folks over at We Mean Business Coalition with RMI's backing, this index sizes up the...

Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

Webull Faces Investor Lawsuit: Compliance in Question

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

Energy Fuels Secures Key Financing for Donald Project

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

IBSSC 2026: A New Chapter in Business Education

Shifts in Business Education at the IBSSC 2026 Boy, oh boy, Shanghai was buzzing the other week. We’re diving into the heart of the 11th International Business School Shanghai Conference (IBSSC). There's a changing of the guard in how business education is viewed, and it was all happening from October 21 to 23 at the Xuhui campus of Shanghai Jiao Tong University. Global...